Effect of LAI Antipsychotics on Relapse Frequency and Adverse Drug Events of Schizophrenia Patients
Introduction: Non-adherence to oral antipsychotic medication is common in schizophrenia patients, and it is very likely to lead to recurrence. Whereas the frequency of recurrence in schizophrenia is associated with poorer long-term outcomes and disease progression. The use of long-acting injectable...
Saved in:
| Main Authors: | Sabar Parluhutan Siregar, Giyanto, Ery Surya Sevriana, Rayi Citra Ayu Pangestuti, Wahyu Ratna Dewi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universitas Airlangga
2025-05-01
|
| Series: | Jurnal Psikiatri Surabaya |
| Online Access: | https://e-journal.unair.ac.id/JPS/article/view/62938 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retrospective cohort study of long-acting injectable (LAI) antipsychotic initiation in the inpatient setting: impact of LAI characteristics on transition and continuation of care among patients with schizophrenia in the USA
by: Rashmi Patel, et al.
Published: (2025-03-01) -
Predictors of relapse after discontinuing antipsychotics in patients with schizophrenia spectrum disorders
by: Ling Li, et al.
Published: (2025-03-01) -
Minimizing Cardiovascular Adverse Effects of Atypical Antipsychotic Drugs in Patients with Schizophrenia
by: Fadi T. Khasawneh, et al.
Published: (2014-01-01) -
Osteoporosis Associated with Antipsychotic Treatment in Schizophrenia
by: Haishan Wu, et al.
Published: (2013-01-01) -
The antipsychotics functional index (AFI) in schizophrenia
by: Gabriel-Cristian Marinescu, et al.
Published: (2025-07-01)